Cargando…

Cerebrospinal fluid biomarkers in various pediatric neurologic diseases

Detalles Bibliográficos
Autor principal:	Lee, Jeongho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Pediatric Society 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841972/ https://www.ncbi.nlm.nih.gov/pubmed/34990541 http://dx.doi.org/10.3345/cep.2021.01445

Ejemplares similares

Investigating Different Forms of Hydrogen Sulfide in Cerebrospinal Fluid of Various Neurological Disorders
por: Greco, Viviana, et al.
Publicado: (2021)

Evaluation of S100B in cerebrospinal fluid as a potential biomarker for neurological diseases in calves
por: KOJIMA, Yuka, et al.
Publicado: (2015)

Cerebrospinal fluid rhinorrhea
por: Mohanty, Aaron
Publicado: (2016)

Transferrin isoforms in cerebrospinal fluid and their relation to neurological diseases
por: MURAKAMI, Yuta, et al.
Publicado: (2019)

The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders
por: Paraskevas, George P.
Publicado: (2022)

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis
por: Welton, Joanne L., et al.
Publicado: (2017)

Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases
por: Hoshi, Kyoka, et al.
Publicado: (2023)

Enigma of cerebrospinal fluid dynamics
por: Klarica, Marijan, et al.
Publicado: (2014)

Human Polyomaviruses in the Cerebrospinal Fluid of Neurological Patients
por: Delbue, Serena, et al.
Publicado: (2019)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
por: Barichello, Tatiana, et al.
Publicado: (2019)

Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2015)

Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases
por: Bothwell, Steven William, et al.
Publicado: (2019)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research
por: Schilde, Lukas M., et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes
por: Chaumont, H., et al.
Publicado: (2023)

Short review of randomized controlled trials for Surgical Neurology International: Part II - drain-associated cerebrospinal fluid infections
por: Lo, Benjamin W. Y., et al.
Publicado: (2019)

Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review
por: Lehner, Kurt R., et al.
Publicado: (2022)

Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus
por: Wang, Tianqi, et al.
Publicado: (2023)

Comparison of cerebellomedullary and lumbar cerebrospinal fluid analysis in dogs with neurological disease
por: Lampe, Rachel, et al.
Publicado: (2020)

Low activity of complement in the cerebrospinal fluid of the patients with various prion diseases
por: Chen, Cao, et al.
Publicado: (2016)

Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis
por: Rosadas, Carolina, et al.
Publicado: (2015)

Exploring the role of cerebrospinal fluid as analyte in neurologic disorders
por: Pingle, Sandeep C, et al.
Publicado: (2023)

The physiology and pathophysiology of cerebrospinal fluid: new evidence
por: Klarica, Marijan, et al.
Publicado: (2021)

Current perioperative management of cerebrospinal fluid drains
por: Zhou, Shao-Feng, et al.
Publicado: (2023)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
por: Molero-Luis, Marta, et al.
Publicado: (2020)

Fluids and Barriers of the CNS: a new journal encompassing Cerebrospinal Fluid Research
por: Jones, Hazel C, et al.
Publicado: (2011)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Cerebrospinal Fluid Biomarkers of Japanese Encephalitis
por: Sengupta, Nabonita, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers in Childhood Leukemias
por: Ikonomidou, Chrysanthy
Publicado: (2021)

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity
por: Virhammar, Johan, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
por: Lee, Jongmin, et al.
Publicado: (2020)

Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms
por: Neumann, Bernhard, et al.
Publicado: (2020)

Hepatitis E Virus Quasispecies in Cerebrospinal Fluid with Neurological Manifestations
por: Abravanel, Florence, et al.
Publicado: (2021)

Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
por: Paterson, Ross W, et al.
Publicado: (2021)

Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases
por: Konen, Franz Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9d1eij5pvhsfiip42hnl0bkr4l